Care

Silicon Valley Bank report predicts VCs will slow down their deal pace in 2022.

This news comes just months after Exscientia went public. 

The company plans to use the funding to expand its commercial team, scale operations and develop new products.

The test reports on the G84E mutation in the HOXB13 gene, which studies have shown increase a person’s risk of developing prostate cancer.

The UAE-based asset owner and investor has announced it is to consolidate several healthcare companies within Pure Health.

The growth of telehealth and remote-monitoring tools could be a game-changer for women's health, particularly maternal and fetal care.

During a panel at CES, leaders at digital therapeutic companies discuss the state of the market right now and what’s needed to boost adoption.

GP who advised on controversial NHS data sharing plan receives damehood. 

Also: Medicare Advantage insurer Zing Health partners with Papa. Verily and biopharma-company Sosei Heptares announce a research collaboration. Pharma-focused accelerator PharmStars’ next cohort will focus on neurological diseases.

The deal comes about a month after Nomi announced it had raked in $110 million in Series A funding.